Drugs / pure platelet-rich plasma
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03300531 | Dec 2017 → Dec 2020 | epicondylitis, rotator cuff syndrome, tendinitis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pure platelet-rich plasma | “Ultrasound-guided pure platelet-rich-plasma (P-PRP) injection” NCT03300531 ↗ |
| Known as | P-PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03300531 ↗ |
| Route | Other | “Pure platelet-rich plasma will be injected into the tendon.” NCT03300531 ↗ |